Evidence map›Paper›PMID 33476232›Full record

ArticleAmerican journal of public health2021

Defeating JUUL's Effort to Rewrite San Francisco's E-Cigarette Regulations.

Neiloy R Sircar, Stanton A Glantz

Abstract read
In one paragraph

Article in American journal of public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Cannabis industry campaign expenditures in Colorado, 2005-2021.The International journal on drug policy · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Neiloy R SircarNeiloy Sircar is a postdoctoral fellow at the Center for Tobacco Control Research and Education at the University of California San Francisco. S. A. Glantz was professor of medicine at the Center for Tobacco Control Research and Education and Institute for Health Policy Studies at the University of California San Francisco until he recently retired.
Stanton A GlantzNeiloy Sircar is a postdoctoral fellow at the Center for Tobacco Control Research and Education at the University of California San Francisco. S. A. Glantz was professor of medicine at the Center for Tobacco Control Research and Education and Institute for Health Policy Studies at the University of California San Francisco until he recently retired.

Funding

Postdoctoral training in tobacco controlR25CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2006 to 2015
$5.4M
Effect of Tobacco Advocacy at the State LevelR01DA043950 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI APOLLONIO, DOROTHY ELINOR · 2016 to 2020
$2.6M
Postdoctoral training in tobacco controlT32CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2016 to 2020
$2.6M
NCI NIH HHS R25 CA113710NCI NIH HHS T32 CA113710NIDA NIH HHS R01 DA043950
6 · The paper itself

Abstract

In 2019, San Francisco, California, prohibited the sale of electronic cigarettes lacking US Food and Drug Administration authorization. JUUL then promoted a ballot initiative (Proposition C) to replace San Francisco's e-cigarette legislation with legislation JUUL wrote that required future legislation to be approved by the voters. JUUL promoted Proposition C as a way to reduce youth e-cigarette use while allowing adult choice.Health groups argued that JUUL's measure could nullify San Francisco's prohibition on selling flavored tobacco products. Health groups benefitted from having an established campaign network that recently defended the flavor ban. They successfully framed Proposition C as a tobacco industry ploy to undo San Francisco's e-cigarette regulations, particularly the prohibition on selling flavored tobacco products. JUUL ended its campaign on September 30, 2019, and the measure failed on election day, with 82% voting against it.Lessons learned from the campaign include the importance of framing an industry initiative as a threat to local public health lawmaking and the potential for the e-cigarette issue to attract parents as new leaders and engage a powerful constituency to support tobacco control measures.

Indexed as

AdolescentAdultCommerceElectronic Nicotine Delivery SystemsHumansPublic HealthPublic PolicySan FranciscoSmoke-Free PolicySmokingTobacco ProductsUnited StatesUnited States Food and Drug AdministrationVaping

Identifiers

PMID33476232
PMCPMC7893333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.